New Benda Pharmaceutical, Inc. Investor Video Brings the Gendicine® Investment Opportunity to Life

HUBEI PROVINCE, China--(BUSINESS WIRE)--Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB:BPMA), a China-based pharmaceutical company producing both Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced today that it has launched a new investor video (www.bendapharma.com/video) to provide investors easy, quick and informative insight into the Benda and Gendicine® investment opportunity. Benda recognizes that investment research can be dry and overwhelming - this dynamic new video gives investors a lively financial introduction to a potential cancer cure.